REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 187 filers reported holding REVANCE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,671,094 | -10.4% | 1,366,268 | +97.8% | 0.05% | -11.5% |
| Q2 2023 | $17,484,983 | +3669.7% | 690,833 | +4697.5% | 0.05% | +5100.0% |
| Q1 2023 | $463,824 | -94.5% | 14,400 | -97.6% | 0.00% | -97.1% |
| Q2 2022 | $8,369,000 | -45.5% | 605,574 | -23.0% | 0.04% | -42.6% |
| Q1 2022 | $15,346,000 | +6.7% | 786,967 | -10.7% | 0.06% | +7.0% |
| Q4 2021 | $14,386,000 | -31.6% | 881,482 | +16.8% | 0.06% | -38.0% |
| Q3 2021 | $21,029,000 | +180.3% | 754,800 | +181.2% | 0.09% | +162.9% |
| Q1 2021 | $7,502,000 | +74.3% | 268,400 | +1.2% | 0.04% | +52.2% |
| Q4 2019 | $4,304,000 | +51.8% | 265,199 | +21.6% | 0.02% | +35.3% |
| Q3 2019 | $2,836,000 | +88.9% | 218,155 | +88.6% | 0.02% | +112.5% |
| Q2 2019 | $1,501,000 | – | 115,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
| Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
| Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
| Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
| Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
| Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
| Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
| TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |